2022: the year in cardiovascular disease - the year of upfront lipid lowering combination therapy.

Banach, Maciej; Reiner, Zeljko; Cicero, Arrigo F G; Sabouret, Pierre; Viigimaa, Margus; Sahebkar, Amirhossein; Postadzhiyan, Arman; Gaita, Dan; Pella, Daniel; Penson, Peter E

Banach, Maciej; Reiner, Zeljko; Cicero, Arrigo F G; Sabouret, Pierre; Viigimaa, Margus; Sahebkar, Amirhossein; Postadzhiyan, Arman; Gaita, Dan; Pella, Daniel; Penson, Peter E.

Afiliación

Banach M; Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland.
Reiner Z; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland.
Cicero AFG; Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research institute (PMMHRI), Lodz, Poland.
Sabouret P; Department of Internal Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
Viigimaa M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Sahebkar A; Hypertension and Cardiovascular Risk Factors Research Center, Medical and Surgical Sciences Department, Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
Postadzhiyan A; Heart Institute and Action Group, Pitié-Salpétrière, Sorbonne University Paris, Paris, France.
Gaita D; Department of Health Technologies, Tallinn University of Technology, Tallinn, Estonia.
Pella D; The North Estonia Medical Centre, Tallinn, Estonia.
Penson PE; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Arch Med Sci ; 18(6): 1429-1434, 2022.

Article en En | MEDLINE | ID: mdl-36457968

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Arch Med Sci Año: 2022 Tipo del documento: Article País de afiliación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google